跳至主要内容
临床试验/NL-OMON40292
NL-OMON40292招募中不适用

The immunological aspects of conventional therapy ((chemo)radiation) for the treatment of head and neck squamous cell carcinoma (HNSCC): an exploratory study. - IMRAD

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients should be at least 18 years of age
  • - Patients should be able and willing to provide informed consent
  • - Patients should have the clinical diagnosis of HNSCC
  • - Tumour should be HPV positive
  • - WHO performance status 0-2
  • - Patients are scheduled for:
  • 1.Primary external beam radiotherapy (EBRT)
  • 2.Primary EBRT with concurrent chemotherapy (Cisplatin);

排除标准

  • - Any medical condition that may interfere with the study objectives
  • - Positive test result for HIV or Hepatitis B or C
  • - Any other active malignancy than cervical cancer.

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

The immunological aspects of conventional therapy... | 临床试验